Are we really in danger of the New Coronavirus?

Just as in many recent global so-called epidemics, this is just another Virus that has been around for a loooooong time.

The hundreds of infection cases recorded in China and other few countries by the new nCoV Coronavirus is almost insignificant if you compare them to the Influenza Virus associated deaths only in the U.S.A. during 2018-2019 (Calculated around 33,157 deaths and around 35,520,883 symptomatic Illnesses associated to Influenza virus)*.

The Coronavirus family of viruses were discovered since the 1960´s and have been considered the causing agents of common flus in adults and children, with some cases of pneumonia or bronchitis. Some other strands of Coronavirus have been blamed for other Viral outbreaks in the past, such as SARS in 2003, which reported 800 deaths worldwide. This new strand of Coronavirus is considered less harmful even.

If you just follow the Conventional Medical news and publicity around these situations, most probably you will feel a surge of fear and danger for yourself and the people around you. You can also perceive the collective fear that is activated in Cities all around. As you might already know, and as is medically proven, fear directly affects the Immune System and makes us more susceptible to all kinds of infections and diseases. The worldwide spread of panic has a strong impact in the world economy, but is very beneficial for the Pharmaceutical Industry.*

*NYTimes Jan 27-2020

All the measures that are recommended by the CDC, the FDA and the Medical associations around the world are based on creating collective fear , therefore contributing to the vulnerability of the population to get “sick or infected”.

It is said that the pharmaceutical industry uses these strategies to launch huge profitable campaigns for antiviral medications, new vaccinations (for which they never publish the significant side effects) and other medical material sales around the world (such as face masks, disinfectant gels, etc.). It is no wonder why the last week the pharma stock market had a considerable rise.*